Tripeptidyl peptidase II in human oral squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 1, 2013, Pages 123-130

  Usukura, Katsuya ^a   Kasamatsu, Atsushi ^a   Okamoto, Atsushi ^a   Kouzu, Yukinao ^a   Higo, Morihiro ^a   Koike, Hirofumi ^a   Sakamoto, Yosuke ^b   Ogawara, Katsunori ^b   Shiiba, Masashi ^b   Tanzawa, Hideki ^a,b   Uzawa, Katsuhiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Oral squamous cell carcinoma; Proliferation; shRNA experiments; Spindle assembly checkpoint

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PROTEIN CCNB1; PROTEIN MAD2; SHORT HAIRPIN RNA; TRIPEPTIDYL PEPTIDASE II; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; M PHASE CELL CYCLE CHECKPOINT; MAJOR CLINICAL STUDY; MOLECULAR MODEL; MOUTH SQUAMOUS CELL CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPEPTIDYL PEPTIDASE II GENE; TUMOR GENE; TUMOR VOLUME; UPREGULATION;

AGED; AMINOPEPTIDASES; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; DOWN-REGULATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOBLOTTING; JAPAN; LYMPHATIC METASTASIS; M PHASE CELL CYCLE CHECKPOINTS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; TRANSFECTION; UP-REGULATION;

EID: 84872345660     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1307-y     Document Type: Article

References (40)

1. Balow RM, Eriksson I (1987) Tripeptidyl peptidase II in haemolysates and liver homogenates of various species. Biochem J 241:75-80
2. Balow RM, Ragnarsson U, Zetterqvist O (1983) Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver. J Biol Chem 258:11622-11628
3. Balow RM, Tomkinson B, Ragnarsson U, Zetterqvist O (1986) Purification, substrate specificity, and classification of tripeptidyl peptidase II. J Biol Chem 261:2409-2417
4. Bassi C, Mello SS, Cardoso RS et al (2008) Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation. Hum Exp Toxicol 27:919-929
5. Castedo M, Perfettini JL, Roumier T, Kroemer G (2002) Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 12:1287-1293
6. De Wulf P, Earnshaw WC (2009) The kinetochore: from molecular discoveries to cancer therapy. Spring Street, New York
7. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa H (2004) Sarcoendoplasmic reticulum Ca2+ ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 110:225-231
8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
9. Hong X, Lei L, Glas R (2003) Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J Exp Med 197:1731-1743
10. Ibrado AM, Kim CN, Bhalla K (1998) Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 12:1930-1936
11. Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, Bukawa H, Yokoe H, Tanzawa H (2005) Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 16:269-273
12. Kato Y, Uzawa K, Yamamoto N, Kouzu Y, Koike H, Shiiba M, Bukawa H, Yokoe H, Shibahara T, Tanzawa H (2007) Overexpression of Septin1: possible contribution to the development of oral cancer. Int J Oncol 31:1021-1028
13. Kouzu Y, Uzawa K, Koike H et al (2006) Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. Br J Cancer 94:717-723
14. Li Y, Gorbea C, Mahaffey D, Rechsteiner M, Benezra R (1997) MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity. Proc Natl Acad Sci USA 94:12431-12436
15. Ling YH, Consoli U, Tornos C, Andreeff M, Perez-Soler R (1998) Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol. Int J Cancer 75:925-932
16. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC (1999) Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59:5724-5731
17. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S (1995) Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 31:181-187
18. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-326
19. Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72:1369-1375
20. May KM, Hardwick KG (2006) The spindle checkpoint. J Cell Sci 119:4139-4142
21. Musacchio A, Hardwick KG (2002) The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol 3:731-741
22. Nomura H, Uzawa K, Yamano Y et al (2009) Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis. Hum Pathol 40:83-91
23. Onda T, Uzawa K, Endo Y, Bukawa H, Yokoe H, Shibahara T, Tanzawa H (2006) Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br J Cancer 94:698-709
24. Roberts BT, Farr KA, Hoyt MA (1994) The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol Cell Biol 14:8282-8291
25. Rose C, Vargas P, Bourgeat J, Schwartz JC (1996) A radioimmunoassay for the tripeptide Gly-Trp-Met, a major metabolite of endogenous cholecystokinin in brain. Neuropeptides 30:231-235
26. Saito K, Uzawa K, Endo Y, Kato Y, Nakashima D, Ogawara K, Shiba M, Bukawa H, Yokoe H, Tanzawa H (2006) Plasma membrane Ca2 + ATPase isoform 1 down-regulated in human oral cancer. Oncol Rep 15:49-55
27. Saitoh S, Kobayashi Y, Ogiyama Y, Takahashi K (2008) Dual regulation of mad2 localization on kinetochores by bub1 and dam1/dash that ensure proper spindle interaction. Mol Biol Cell 19:3885-3897
28. Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, Shibahara T, Tanzawa H (2006) Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 29:117-124
29. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H (2005) Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92:1915-1921
30. Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG (2005) Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. Cancer Res 65:1361-1368
31. Stavropoulou V, Vasquez V, Cereser B, Freda E, Masucci MG (2006) TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints. Biochem Biophys Res Commun 346:415-425
32. Sudbo J, Reith A (2005) The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 115:339-345
33. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H (2003) Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82:607-611
34. Tomkinson B, Lindås AC (2005) Tripeptidyl-peptidase II: a multi-purpose peptidase. Int J Biochem Cell Biol 37:1933-1937
35. Tomkinson B, Hansen M, Cheung WF (1997) Structure-function studies of recombinant murine tripeptidyl-peptidase II: the extra domain which is subject to alternative splicing is involved in complex formation. FEBS Lett 405:277-280
36. Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG (2010) Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 42:736-739
37. Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F et al (1998) Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 91:3711-3723
38. Wang TH, Wang HS, Soong YK (2000) Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88:2619-2628
39. Wassmann K, Benezra R (1998) Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc Natl Acad Sci USA 95:11193-11198
40. Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H (2008) Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Int J Oncol 32:1001-1009